Thomas Hultsch

5.7k total citations · 1 hit paper
44 papers, 2.4k citations indexed

About

Thomas Hultsch is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Thomas Hultsch has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Dermatology, 25 papers in Immunology and Allergy and 16 papers in Physiology. Recurrent topics in Thomas Hultsch's work include Dermatology and Skin Diseases (30 papers), Allergic Rhinitis and Sensitization (21 papers) and Asthma and respiratory diseases (15 papers). Thomas Hultsch is often cited by papers focused on Dermatology and Skin Diseases (30 papers), Allergic Rhinitis and Sensitization (21 papers) and Asthma and respiratory diseases (15 papers). Thomas Hultsch collaborates with scholars based in United States, Germany and Switzerland. Thomas Hultsch's co-authors include R J Hohman, Gianluca Pirozzi, Ulrich Wahn, Neil M.H. Graham, Jonathan M. Spergel, Alexander Kapp, Georg Stingl, Z. Chen, Peter Maximilian Heil and Dieter Maurer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PEDIATRICS.

In The Last Decade

Thomas Hultsch

44 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

2017 344 citations Marjolein de Bruin‐Weller, Diamant Thaçi et al. British Journal of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Hultsch United States	22	1.6k	1.6k	814	413	283	44	2.4k
Wolfgang Czech Germany	21	733 0.4×	716 0.5×	649 0.8×	710 1.7×	311 1.1×	45	1.8k
Benjamin Ungar United States	21	2.2k 1.4×	1.4k 0.9×	781 1.0×	624 1.5×	413 1.5×	68	2.7k
Danuta Gutowska‐Owsiak United Kingdom	16	951 0.6×	565 0.4×	471 0.6×	1.1k 2.6×	210 0.7×	37	2.0k
Xiuzhong Zheng United States	21	2.2k 1.4×	1.4k 0.9×	786 1.0×	720 1.7×	316 1.1×	22	2.7k
Yiannis Vasilopoulos Greece	18	1.0k 0.6×	710 0.5×	279 0.3×	357 0.9×	183 0.6×	50	1.7k
Juhan Yoon United States	16	455 0.3×	418 0.3×	544 0.7×	892 2.2×	167 0.6×	18	1.5k
Inna Cueto United States	18	936 0.6×	347 0.2×	383 0.5×	895 2.2×	247 0.9×	27	1.6k
Faiz Ahmad United States	16	461 0.3×	236 0.2×	242 0.3×	224 0.5×	177 0.6×	25	958
Israel Coats United States	11	773 0.5×	296 0.2×	297 0.4×	723 1.8×	155 0.5×	11	1.2k
Masayuki Kitajima Japan	16	357 0.2×	288 0.2×	350 0.4×	482 1.2×	82 0.3×	65	1.3k

Countries citing papers authored by Thomas Hultsch

Since Specialization

Citations

This map shows the geographic impact of Thomas Hultsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hultsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hultsch more than expected).

Fields of papers citing papers by Thomas Hultsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hultsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hultsch. The network helps show where Thomas Hultsch may publish in the future.

Co-authorship network of co-authors of Thomas Hultsch

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hultsch. A scholar is included among the top collaborators of Thomas Hultsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hultsch. Thomas Hultsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Otto, Martin, Thomas Hultsch, Volker Hoffmann, et al.. (2025). Mechanisms of laminar flow controlled in vitro corrosion of a biodegradable Fe-Mn-C steel. Corrosion Science. 249. 112860–112860. 1 indexed citations

Boguniewicz, Mark, Diamant Thaçi, Peter Lio, et al.. (2019). Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ). Journal of Allergy and Clinical Immunology. 143(2). AB123–AB123. 4 indexed citations

Wollenberg, Andreas, Lisa A. Beck, Andrew Blauvelt, et al.. (2019). Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS). British Journal of Dermatology. 182(5). 1120–1135. 91 indexed citations

Callewaert, Chris, Teruaki Nakatsuji, Rob Knight, et al.. (2019). IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis. Journal of Investigative Dermatology. 140(1). 191–202.e7. 158 indexed citations

Silverberg, Jonathan I., Eric L. Simpson, Marius Ardeleanu, et al.. (2019). Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials. British Journal of Dermatology. 181(1). 80–87. 44 indexed citations

Paller, Amy S., Ashish Bansal, Eric L. Simpson, et al.. (2019). Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial. American Journal of Clinical Dermatology. 21(1). 119–131. 55 indexed citations

Simpson, Eric L., Thomas Bieber, Marjolein de Bruin‐Weller, et al.. (2018). 489 Dupilumab efficacy in atopic dermatitis in four randomized phase 3 trials (liberty ad solo 1&2, chromos, cafe). Journal of Investigative Dermatology. 138(5). S83–S83. 1 indexed citations

Callewaert, Chris, Rob Knight, Teruaki Nakatsuji, et al.. (2018). LB1505 Dupilumab-mediated IL-4Rα blockade decreases Staphylococcus aureus colonization and increases microbial diversity in patients with Atopic Dermatitis (AD). Journal of Investigative Dermatology. 138(9). B7–B7. 1 indexed citations

Leung, Donald Y.M., Jon M. Hanifin, David M. Pariser, et al.. (2009). Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. British Journal of Dermatology. 161(2). 435–443. 33 indexed citations

10.

Spergel, Jonathan M., Mark Boguniewicz, Amy S. Paller, et al.. (2007). Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. British Journal of Dermatology. 157(2). 378–381. 11 indexed citations

11.

Ling, Mark, Mark Lebwohl, David M. Pariser, et al.. (2004). Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study. Journal of the American Academy of Dermatology. 51(5). 731–738. 95 indexed citations

12.

Kuehr, Joachim, Stefan Zielen, U. Schauer, et al.. (2002). Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 109(2). 274–280. 262 indexed citations

13.

Kopp, Matthias, Gabriele Ihorst, Wolfgang Kamin, et al.. (2002). The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 110(5). 728–735. 66 indexed citations

14.

Bellinghausen, Iris, et al.. (1999). Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cells. Journal of Allergy and Clinical Immunology. 103(2). 326–332. 101 indexed citations

15.

Hultsch, Thomas, et al.. (1998). Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. Archives of Dermatological Research. 290(9). 501–507. 67 indexed citations

16.

Hultsch, Thomas, P. W. J. L. Brand, Suzanne M. Lohmann, et al.. (1998). Direct evidence that FK506 inhibition of FcεRI-mediated exocytosis from RBL mast cells involves calcineurin. Archives of Dermatological Research. 290(5). 258–263. 20 indexed citations

17.

Mohamadzadeh, Mansour, et al.. (1994). Enhanced expression of IL‐8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers., tolerogens and irritants. Experimental Dermatology. 3(6). 298–303. 47 indexed citations

18.

Hultsch, Thomas, Roland Martinꝉ, & R J Hohman. (1992). The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines.. Molecular Biology of the Cell. 3(9). 981–987. 23 indexed citations

19.

Hultsch, Thomas, et al.. (1988). The Role of Chymase in Ionophore-Induced Histamine Release from Human Pulmonary Mast Cells. Advances in experimental medicine and biology. 240. 133–136. 6 indexed citations

20.

Hultsch, Thomas, et al.. (1988). The effect of serine esterase inhibitors on ionophore-induced histamine release from human pulmonary mast cells. Inflammation Research. 23(3-4). 198–200. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact